Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly (ACP-PEACE)

December 18, 2023 updated by: James A. Tulsky, Dana-Farber Cancer Institute

Improving Advance Care Planning in Oncology: A Pragmatic, Cluster-Randomized Trial Integrating Patient Videos and Clinician Communication Training

In this research study, the investigators are working to help oncologists better serve patients by delivering more patient-centered, goal-concordant care that may improve health care delivery.

- It is expected that about 30,000 people will take part in this research study, 29,550 of these patients, the vast majority, will be included only for medical record review.

Study Overview

Detailed Description

The purpose of this study is to improve the quality of care provided to millions of older Americans with cancer. The investigators are working to help oncologists better serve patients by delivering more patient-centered, goal-concordant care that may dramatically improve health care delivery.

This is pragmatic stepped wedge cluster randomized trial (SW-CRT) of a Comprehensive ACP (Advance Care Planning) Program among older oncology patients. The ACP Program will include training clinicians in communication skills and using video decision aids for participants.

- This study will involve medical record review of 30,000 people age 65 or older with advanced cancer.

We will also recruit 450 eligible patients (150 patients from each of our three sites broken down into 75 patients during the control phase and 75 patients during the intervention phase) to conduct a survey for our secondary patient-centered outcomes (confidence, satisfaction with physician communication, patient decisional satisfaction and regret). From among this sub-group we will engage 240 participants (80 from each of our three sites broken down into 40 patients during the control phase and 40 patients during the intervention phase) in an activity to film video declarations of their preferences.

During the first year, three pilot sites (one at each health care system) will trial the intervention. The subjects recruited at these pilot sites will not be included in the final analysis. Thus, the main trial will begin during year 2 and continue through year 5 with recruitment of 30,000 subjects for the primary outcome at 30 oncology clinics. The first year pilot will serve to inform the larger roll-out and the intervention may change during the first year based on pilot-clinic experience.

Study Type

Interventional

Enrollment (Estimated)

30000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02215
        • Dana Farber Cancer Institute
    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic
    • New York
      • New Hyde Park, New York, United States, 11040
        • Northwell Health
    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria for clinics:

Clinic eligibility criteria include:

  • More than one oncologist
  • Serve a patient population that is at least 30% aged 65 or older
  • Disease-based oncology clinic

Subject Eligibility: (for the in-person surveys):

- Any patient affiliated with one of the study clinics who speaks English and is aged 65 or older with advanced cancer is eligible for participation. Advanced cancer is defined as metastatic disease for solid tumors and recurrent or refractory disease for hematological malignancies. There are no exclusions based on gender, race, or ethnicity.

Exclusion Criteria:

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Advance Care Planning

-Survey:

  • A group of older patients with advanced cancer (N=450) will have a survey over the course of the 36 months of recruitment.
  • Participants will be provided written copies of the questions to follow along during the interviews
Communication skills training
Other Names:
  • Vital Talk Communication Skills Training
ACP Decisions video decision aids
Experimental: Advance Care Planning-Video Declaration

Video Declaration:

  • From among this group of 450 participants, the video declaration of preferences activity will be conducted with 240 patients.
  • For those participants that agree to the video declaration, they will proceed with recording of their video declarations
  • The RA will begin by reading a standardized introduction to aid the subject do the video
Communication skills training
Other Names:
  • Vital Talk Communication Skills Training
ACP Decisions video decision aids
Recording of patient advance care planning videos
Other: Comprehensive Record Review of ACP
  • A review of Medical orders for resuscitation preferences in the electronic health record
  • A review of Medical orders for Palliative care consultations preferences in the electronic health record
  • A review of Medical orders for Hospice use preferences in the electronic health record
Communication skills training
Other Names:
  • Vital Talk Communication Skills Training
ACP Decisions video decision aids
Recording of patient advance care planning videos
Experimental: Main Study Arm
Patients with cancer being seen at the 30 oncology clinics will be exposed to clinicians who have had communication skills training (Vital Talk) and who are using video decision aids (ACP Decisions). Our main outcome is advance care planning documentation.
Communication skills training
Other Names:
  • Vital Talk Communication Skills Training
ACP Decisions video decision aids
Recording of patient advance care planning videos

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Advance Care Planning Documentation
Time Frame: 4 years
Any advance directive (e.g., living will, POLST, etc.) and changes of resuscitation orders or any indication in the EHR of a goals-of-care or advance care planning conversation
4 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of Preferences for Resuscitation
Time Frame: 4 years
Documented choices regarding CPR and mechanical ventilation in the EHR
4 years
Rate of Palliative Care Consultation
Time Frame: 4 years
Use of palliative care services (consults, outpatient visits) in the EHR
4 years
Rate of Hospice Use
Time Frame: 4 years
Use of hospice documented in the EHR
4 years
Confidence in Future Care
Time Frame: 4 years
(in person survey) patient confidence that they will receive the right care at the right time by their health system
4 years
Communication and Decisional Satisfaction
Time Frame: 4 years
(In person survey) patient satisfaction with communication and decision making
4 years
Decisional Regret
Time Frame: 4 years
(In person survey) patient regret regarding decision making
4 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: James A. Tulsky, MD, Dana-Farber Cancer Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 18, 2018

Primary Completion (Estimated)

September 30, 2024

Study Completion (Estimated)

September 30, 2024

Study Registration Dates

First Submitted

July 25, 2018

First Submitted That Met QC Criteria

July 25, 2018

First Posted (Actual)

August 1, 2018

Study Record Updates

Last Update Posted (Estimated)

December 19, 2023

Last Update Submitted That Met QC Criteria

December 18, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 18-276
  • UG3AG060626 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Other Cancer

Clinical Trials on Clinician Communication Skills Training

3
Subscribe